| Dr Frank J Groshek, MD | |
|
2002 Medical Pkwy Ste 235, Annapolis, MD 21401-3260 | |
| (410) 266-2770 | |
| (410) 841-6251 |
| Full Name | Dr Frank J Groshek |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 16 Years |
| Location | 2002 Medical Pkwy Ste 235, Annapolis, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093977415 | NPI | - | NPPES |
| 1093977415 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0204X | Radiology - Vascular & Interventional Radiology | MD041503 (District Of Columbia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Anne Arundel Medical Center | Annapolis, MD | Hospital |
| Doctors' Community Hospital | Lanham, MD | Hospital |
| Medstar Franklin Square Medical Center | Baltimore, MD | Hospital |
| Medstar Union Memorial Hospital | Baltimore, MD | Hospital |
| Medstar Good Samaritan Hospital | Baltimore, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Brown, Croft, Frazier, Pa | 9537101746 | 24 |
| Luminis Health Imaging, Inc. | 8729054598 | 25 |
| Medstar Medical Group Radiology Llc | 1557589157 | 161 |
| Physician Imaging Of Washington Hospital Center Llc | 6204910292 | 81 |
| Brown, Croft, Frazier, Pa | 9537101746 | 24 |
| Luminis Health Imaging, Inc. | 8729054598 | 25 |
| Medstar Medical Group Radiology Llc | 1557589157 | 161 |
| Physician Imaging Of Washington Hospital Center Llc | 6204910292 | 81 |
News Archive
Antisense Therapeutics is pleased to report the publication of previously generated Phase IIa clinical trial data on ATL1102 in the medical journal Neurology.
Molecular Insight Pharmaceuticals, Inc. today announced that it has completed an agreement to sub-license its Onalta™ brand 90-Y edotreotide radiotherapeutic in certain countries in Europe, the Middle East, North Africa, Russia and Turkey to BioMedica Life Sciences, S.A., Athens, Greece.
Scientists at Singapore's Nanyang Technological University (NTU Singapore) have created a paper-like material derived from pollen that bends and curls in response to changing levels of environmental humidity.
New York University researchers revealed that data from previously completed withdrawal to monotherapy studies for antiepileptic drugs provide a valid control for future studies, obviating the need for placebo/pseudo-placebo trials to demonstrate the efficacy of these drugs as monotherapy. Results of this study are now available online in Epilepsia, a journal published by Wiley-Blackwell on behalf of the International League Against Epilepsy.
One of Southern California's largest hospital systems is teaming up with hundreds of doctors in a new alliance designed to better manage patient care, improve medical outcomes and reduce costs. Under the partnership with Providence Health & Services of Southern California, doctors will share and analyze data about diabetes, congestive heart failure and other conditions to identify effective practices and eliminate inefficiencies that drive up expenses.
› Verified 6 days ago
| Entity Name | Luminis Health Imaging, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194825240 PECOS PAC ID: 8729054598 Enrollment ID: O20041228000266 |
News Archive
Antisense Therapeutics is pleased to report the publication of previously generated Phase IIa clinical trial data on ATL1102 in the medical journal Neurology.
Molecular Insight Pharmaceuticals, Inc. today announced that it has completed an agreement to sub-license its Onalta™ brand 90-Y edotreotide radiotherapeutic in certain countries in Europe, the Middle East, North Africa, Russia and Turkey to BioMedica Life Sciences, S.A., Athens, Greece.
Scientists at Singapore's Nanyang Technological University (NTU Singapore) have created a paper-like material derived from pollen that bends and curls in response to changing levels of environmental humidity.
New York University researchers revealed that data from previously completed withdrawal to monotherapy studies for antiepileptic drugs provide a valid control for future studies, obviating the need for placebo/pseudo-placebo trials to demonstrate the efficacy of these drugs as monotherapy. Results of this study are now available online in Epilepsia, a journal published by Wiley-Blackwell on behalf of the International League Against Epilepsy.
One of Southern California's largest hospital systems is teaming up with hundreds of doctors in a new alliance designed to better manage patient care, improve medical outcomes and reduce costs. Under the partnership with Providence Health & Services of Southern California, doctors will share and analyze data about diabetes, congestive heart failure and other conditions to identify effective practices and eliminate inefficiencies that drive up expenses.
› Verified 6 days ago
| Entity Name | Physician Imaging Of Washington Hospital Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831385871 PECOS PAC ID: 6204910292 Enrollment ID: O20080229000143 |
News Archive
Antisense Therapeutics is pleased to report the publication of previously generated Phase IIa clinical trial data on ATL1102 in the medical journal Neurology.
Molecular Insight Pharmaceuticals, Inc. today announced that it has completed an agreement to sub-license its Onalta™ brand 90-Y edotreotide radiotherapeutic in certain countries in Europe, the Middle East, North Africa, Russia and Turkey to BioMedica Life Sciences, S.A., Athens, Greece.
Scientists at Singapore's Nanyang Technological University (NTU Singapore) have created a paper-like material derived from pollen that bends and curls in response to changing levels of environmental humidity.
New York University researchers revealed that data from previously completed withdrawal to monotherapy studies for antiepileptic drugs provide a valid control for future studies, obviating the need for placebo/pseudo-placebo trials to demonstrate the efficacy of these drugs as monotherapy. Results of this study are now available online in Epilepsia, a journal published by Wiley-Blackwell on behalf of the International League Against Epilepsy.
One of Southern California's largest hospital systems is teaming up with hundreds of doctors in a new alliance designed to better manage patient care, improve medical outcomes and reduce costs. Under the partnership with Providence Health & Services of Southern California, doctors will share and analyze data about diabetes, congestive heart failure and other conditions to identify effective practices and eliminate inefficiencies that drive up expenses.
› Verified 6 days ago
| Entity Name | Medstar Medical Group Radiology Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326450156 PECOS PAC ID: 1557589157 Enrollment ID: O20140826000263 |
News Archive
Antisense Therapeutics is pleased to report the publication of previously generated Phase IIa clinical trial data on ATL1102 in the medical journal Neurology.
Molecular Insight Pharmaceuticals, Inc. today announced that it has completed an agreement to sub-license its Onalta™ brand 90-Y edotreotide radiotherapeutic in certain countries in Europe, the Middle East, North Africa, Russia and Turkey to BioMedica Life Sciences, S.A., Athens, Greece.
Scientists at Singapore's Nanyang Technological University (NTU Singapore) have created a paper-like material derived from pollen that bends and curls in response to changing levels of environmental humidity.
New York University researchers revealed that data from previously completed withdrawal to monotherapy studies for antiepileptic drugs provide a valid control for future studies, obviating the need for placebo/pseudo-placebo trials to demonstrate the efficacy of these drugs as monotherapy. Results of this study are now available online in Epilepsia, a journal published by Wiley-Blackwell on behalf of the International League Against Epilepsy.
One of Southern California's largest hospital systems is teaming up with hundreds of doctors in a new alliance designed to better manage patient care, improve medical outcomes and reduce costs. Under the partnership with Providence Health & Services of Southern California, doctors will share and analyze data about diabetes, congestive heart failure and other conditions to identify effective practices and eliminate inefficiencies that drive up expenses.
› Verified 6 days ago
| Entity Name | Brown, Croft, Frazier, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902807324 PECOS PAC ID: 9537101746 Enrollment ID: O20240111000011 |
News Archive
Antisense Therapeutics is pleased to report the publication of previously generated Phase IIa clinical trial data on ATL1102 in the medical journal Neurology.
Molecular Insight Pharmaceuticals, Inc. today announced that it has completed an agreement to sub-license its Onalta™ brand 90-Y edotreotide radiotherapeutic in certain countries in Europe, the Middle East, North Africa, Russia and Turkey to BioMedica Life Sciences, S.A., Athens, Greece.
Scientists at Singapore's Nanyang Technological University (NTU Singapore) have created a paper-like material derived from pollen that bends and curls in response to changing levels of environmental humidity.
New York University researchers revealed that data from previously completed withdrawal to monotherapy studies for antiepileptic drugs provide a valid control for future studies, obviating the need for placebo/pseudo-placebo trials to demonstrate the efficacy of these drugs as monotherapy. Results of this study are now available online in Epilepsia, a journal published by Wiley-Blackwell on behalf of the International League Against Epilepsy.
One of Southern California's largest hospital systems is teaming up with hundreds of doctors in a new alliance designed to better manage patient care, improve medical outcomes and reduce costs. Under the partnership with Providence Health & Services of Southern California, doctors will share and analyze data about diabetes, congestive heart failure and other conditions to identify effective practices and eliminate inefficiencies that drive up expenses.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Frank J Groshek, MD 1150 Varnum St Ne, Department Of Radiology, Washington, DC 20017-2104 Ph: (202) 269-7000 | Dr Frank J Groshek, MD 2002 Medical Pkwy Ste 235, Annapolis, MD 21401-3260 Ph: (410) 266-2770 |
News Archive
Antisense Therapeutics is pleased to report the publication of previously generated Phase IIa clinical trial data on ATL1102 in the medical journal Neurology.
Molecular Insight Pharmaceuticals, Inc. today announced that it has completed an agreement to sub-license its Onalta™ brand 90-Y edotreotide radiotherapeutic in certain countries in Europe, the Middle East, North Africa, Russia and Turkey to BioMedica Life Sciences, S.A., Athens, Greece.
Scientists at Singapore's Nanyang Technological University (NTU Singapore) have created a paper-like material derived from pollen that bends and curls in response to changing levels of environmental humidity.
New York University researchers revealed that data from previously completed withdrawal to monotherapy studies for antiepileptic drugs provide a valid control for future studies, obviating the need for placebo/pseudo-placebo trials to demonstrate the efficacy of these drugs as monotherapy. Results of this study are now available online in Epilepsia, a journal published by Wiley-Blackwell on behalf of the International League Against Epilepsy.
One of Southern California's largest hospital systems is teaming up with hundreds of doctors in a new alliance designed to better manage patient care, improve medical outcomes and reduce costs. Under the partnership with Providence Health & Services of Southern California, doctors will share and analyze data about diabetes, congestive heart failure and other conditions to identify effective practices and eliminate inefficiencies that drive up expenses.
› Verified 6 days ago
Luqman K Dad, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 2002 Medical Pkwy, Suite 235, Annapolis, MD 21401 Phone: 410-266-2770 Fax: 410-841-6251 | |
Dr. Quang Nguyen, Radiology Medicare: Accepting Medicare Assignments Practice Location: 2001 Medical Pkwy, Annapolis, MD 21401 Phone: 410-266-2770 Fax: 410-841-6251 | |
Dr. Mark S Radowich, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2002 Medical Pkwy, Suite 235, Annapolis, MD 21401 Phone: 410-266-2770 Fax: 410-841-6251 | |
Dr. Thomas B. Lank, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 122 Defense Hwy, Chesapeake Medical Imaging, Annapolis, MD 21401 Phone: 410-571-0350 Fax: 410-571-9348 | |
Dr. Mark Cameron Davis, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 845 Coachway, Annapolis, MD 21401 Phone: 952-595-1100 Fax: 612-294-4903 | |
Dr. Kerry J. Thompson, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2002 Medical Pkwy, Suite #235, Annapolis, MD 21401 Phone: 410-266-2770 Fax: 410-841-6251 |